DZNE Munich
Brain diseases such as Alzheimer’s, Parkinson’s, and frontotemporal dementia have one thing in common despite different symptoms: The nerve cells atrophy and die. With this in mind, the…
Study in “Cell”.
Study in “Cell”
Bonn/Berlin, Germany, July 3, 2024. Dexamethasone is one of the most important drugs in the treatment of severe COVID-19, but patients respond very differently to…
Research areas / focus
The group of Prof. Gasser focuses on the study of Parkinson's syndrome, which is the second most common neurodegenerative disease after Alzheimer's disease with steadily…
Investment Opportunities
We are seeking investors to fund the clinical development of this groundbreaking vaccine. There are several opportunities to get involved:
Co-development Partnerships …
DZNE Rostock / Greifswald
Older people in particular develop Alzheimer’s disease or one of the other diseases grouped under the term “dementia.” To this day, there is no long-term effective therapy…
DZNE Dresden
The brain changes throughout a person’s entire life. Its structure and function are directly related to each other. This reciprocal relationship is called plasticity. The scientists at…
Cooperation partners
Networks
DZNE Magdeburg
In Magdeburg, the DZNE is researching the basis for new therapies against Alzheimer’s and other diseases of the nervous system, directing its attention…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
